Eliminating Transfusion in Primary Joint Arthroplasty—An Achievable Goal

Eliminating Transfusion in Primary Joint Arthroplasty—An Achievable Goal

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of arthroplasty 2014-08, Vol.29 (8), p.1511-1511
Hauptverfasser: Krebs, Viktor, MD, Hozack, W.J., MD, Callaghan, John J., MD, Bohannon Mason, J., MD, Mont, Michael, MD, Parvizi, Javad, MD
Format: Artikel
Sprache:eng
Schlagworte:
Antifibrinolytic Agents - therapeutic use
Arthroplasty - adverse effects
Blood Loss, Surgical - prevention & control
Blood Transfusion
Goals
Humans
Orthopedics
Tranexamic Acid - therapeutic use
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1511
container_issue 8
container_start_page 1511
container_title The Journal of arthroplasty
container_volume 29
creator Krebs, Viktor, MD
Hozack, W.J., MD
Callaghan, John J., MD
Bohannon Mason, J., MD
Mont, Michael, MD
Parvizi, Javad, MD
description
doi_str_mv 10.1016/j.arth.2014.07.014
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1551027281</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S088354031400480X</els_id><sourcerecordid>1551027281</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-fcf31a883e11fc5b054d74eca86c7b13d04270d952d74123caf432e48ea1d0df3</originalsourceid><addsrcrecordid>eNp9UU1rFEEQbUQxa8wf8CBz9DJjVX_sjCDCEpJoCBhIhNya3p4a02tv99o9E9ibP8Jf6C-xh40ePHh6ULz3qt4rxl4hNAi4fLtpTBrvGw4oG2ibAk_YApXgdSdh-ZQtoOtErSSII_Yi5w0AolLyOTviCjrFkS_Y5Zl3WxfM6MLX6jaZkIcpuxgqF6rr5LYm7avL6MJYrcquFHfe5HH_68fPVahW9t7Rg1l7qi6i8S_Zs8H4TCePeMy-nJ_dnn6srz5ffDpdXdVWIo71YAeBplxGiINVa1CybyVZ0y1tu0bRg-Qt9O8UL2PkwppBCk6yI4M99IM4Zm8OvrsUv0-UR7112ZL3JlCcsi4ZEXjLOyxUfqDaFHNONOjdIZNG0HOHeqPnDvXcoYZWFyii14_-03pL_V_Jn9IK4f2BQCXlg6Oks3UULPUukR11H93__T_8I7feBWeN_0Z7yps4pVD606gz16Bv5i_OT0QJIDu4E78BpDWYbw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1551027281</pqid></control><display><type>article</type><title>Eliminating Transfusion in Primary Joint Arthroplasty—An Achievable Goal</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Krebs, Viktor, MD ; Hozack, W.J., MD ; Callaghan, John J., MD ; Bohannon Mason, J., MD ; Mont, Michael, MD ; Parvizi, Javad, MD</creator><contributor>Parvizi, Javad</contributor><creatorcontrib>Krebs, Viktor, MD ; Hozack, W.J., MD ; Callaghan, John J., MD ; Bohannon Mason, J., MD ; Mont, Michael, MD ; Parvizi, Javad, MD ; Parvizi, Javad</creatorcontrib><identifier>ISSN: 0883-5403</identifier><identifier>EISSN: 1532-8406</identifier><identifier>DOI: 10.1016/j.arth.2014.07.014</identifier><identifier>PMID: 25085212</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Antifibrinolytic Agents - therapeutic use ; Arthroplasty - adverse effects ; Blood Loss, Surgical - prevention &amp; control ; Blood Transfusion ; Goals ; Humans ; Orthopedics ; Tranexamic Acid - therapeutic use</subject><ispartof>The Journal of arthroplasty, 2014-08, Vol.29 (8), p.1511-1511</ispartof><rights>2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-fcf31a883e11fc5b054d74eca86c7b13d04270d952d74123caf432e48ea1d0df3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.arth.2014.07.014$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25085212$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Parvizi, Javad</contributor><creatorcontrib>Krebs, Viktor, MD</creatorcontrib><creatorcontrib>Hozack, W.J., MD</creatorcontrib><creatorcontrib>Callaghan, John J., MD</creatorcontrib><creatorcontrib>Bohannon Mason, J., MD</creatorcontrib><creatorcontrib>Mont, Michael, MD</creatorcontrib><creatorcontrib>Parvizi, Javad, MD</creatorcontrib><title>Eliminating Transfusion in Primary Joint Arthroplasty—An Achievable Goal</title><title>The Journal of arthroplasty</title><addtitle>J Arthroplasty</addtitle><subject>Antifibrinolytic Agents - therapeutic use</subject><subject>Arthroplasty - adverse effects</subject><subject>Blood Loss, Surgical - prevention &amp; control</subject><subject>Blood Transfusion</subject><subject>Goals</subject><subject>Humans</subject><subject>Orthopedics</subject><subject>Tranexamic Acid - therapeutic use</subject><issn>0883-5403</issn><issn>1532-8406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UU1rFEEQbUQxa8wf8CBz9DJjVX_sjCDCEpJoCBhIhNya3p4a02tv99o9E9ibP8Jf6C-xh40ePHh6ULz3qt4rxl4hNAi4fLtpTBrvGw4oG2ibAk_YApXgdSdh-ZQtoOtErSSII_Yi5w0AolLyOTviCjrFkS_Y5Zl3WxfM6MLX6jaZkIcpuxgqF6rr5LYm7avL6MJYrcquFHfe5HH_68fPVahW9t7Rg1l7qi6i8S_Zs8H4TCePeMy-nJ_dnn6srz5ffDpdXdVWIo71YAeBplxGiINVa1CybyVZ0y1tu0bRg-Qt9O8UL2PkwppBCk6yI4M99IM4Zm8OvrsUv0-UR7112ZL3JlCcsi4ZEXjLOyxUfqDaFHNONOjdIZNG0HOHeqPnDvXcoYZWFyii14_-03pL_V_Jn9IK4f2BQCXlg6Oks3UULPUukR11H93__T_8I7feBWeN_0Z7yps4pVD606gz16Bv5i_OT0QJIDu4E78BpDWYbw</recordid><startdate>20140801</startdate><enddate>20140801</enddate><creator>Krebs, Viktor, MD</creator><creator>Hozack, W.J., MD</creator><creator>Callaghan, John J., MD</creator><creator>Bohannon Mason, J., MD</creator><creator>Mont, Michael, MD</creator><creator>Parvizi, Javad, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140801</creationdate><title>Eliminating Transfusion in Primary Joint Arthroplasty—An Achievable Goal</title><author>Krebs, Viktor, MD ; Hozack, W.J., MD ; Callaghan, John J., MD ; Bohannon Mason, J., MD ; Mont, Michael, MD ; Parvizi, Javad, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-fcf31a883e11fc5b054d74eca86c7b13d04270d952d74123caf432e48ea1d0df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Antifibrinolytic Agents - therapeutic use</topic><topic>Arthroplasty - adverse effects</topic><topic>Blood Loss, Surgical - prevention &amp; control</topic><topic>Blood Transfusion</topic><topic>Goals</topic><topic>Humans</topic><topic>Orthopedics</topic><topic>Tranexamic Acid - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krebs, Viktor, MD</creatorcontrib><creatorcontrib>Hozack, W.J., MD</creatorcontrib><creatorcontrib>Callaghan, John J., MD</creatorcontrib><creatorcontrib>Bohannon Mason, J., MD</creatorcontrib><creatorcontrib>Mont, Michael, MD</creatorcontrib><creatorcontrib>Parvizi, Javad, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of arthroplasty</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krebs, Viktor, MD</au><au>Hozack, W.J., MD</au><au>Callaghan, John J., MD</au><au>Bohannon Mason, J., MD</au><au>Mont, Michael, MD</au><au>Parvizi, Javad, MD</au><au>Parvizi, Javad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eliminating Transfusion in Primary Joint Arthroplasty—An Achievable Goal</atitle><jtitle>The Journal of arthroplasty</jtitle><addtitle>J Arthroplasty</addtitle><date>2014-08-01</date><risdate>2014</risdate><volume>29</volume><issue>8</issue><spage>1511</spage><epage>1511</epage><pages>1511-1511</pages><issn>0883-5403</issn><eissn>1532-8406</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25085212</pmid><doi>10.1016/j.arth.2014.07.014</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0883-5403
ispartof The Journal of arthroplasty, 2014-08, Vol.29 (8), p.1511-1511
issn 0883-5403
1532-8406
language eng
recordid cdi_proquest_miscellaneous_1551027281
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Antifibrinolytic Agents - therapeutic use
Arthroplasty - adverse effects
Blood Loss, Surgical - prevention & control
Blood Transfusion
Goals
Humans
Orthopedics
Tranexamic Acid - therapeutic use
title Eliminating Transfusion in Primary Joint Arthroplasty—An Achievable Goal
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T16%3A58%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eliminating%20Transfusion%20in%20Primary%20Joint%20Arthroplasty%E2%80%94An%20Achievable%20Goal&rft.jtitle=The%20Journal%20of%20arthroplasty&rft.au=Krebs,%20Viktor,%20MD&rft.date=2014-08-01&rft.volume=29&rft.issue=8&rft.spage=1511&rft.epage=1511&rft.pages=1511-1511&rft.issn=0883-5403&rft.eissn=1532-8406&rft_id=info:doi/10.1016/j.arth.2014.07.014&rft_dat=%3Cproquest_cross%3E1551027281%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1551027281&rft_id=info:pmid/25085212&rft_els_id=1_s2_0_S088354031400480X&rfr_iscdi=true